ATE273386T1 - Menschliches cyclin e - Google Patents
Menschliches cyclin eInfo
- Publication number
- ATE273386T1 ATE273386T1 AT92920511T AT92920511T ATE273386T1 AT E273386 T1 ATE273386 T1 AT E273386T1 AT 92920511 T AT92920511 T AT 92920511T AT 92920511 T AT92920511 T AT 92920511T AT E273386 T1 ATE273386 T1 AT E273386T1
- Authority
- AT
- Austria
- Prior art keywords
- human cyclin
- cyclin
- polypeptide
- determining
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76430991A | 1991-09-20 | 1991-09-20 | |
| PCT/US1992/007866 WO1993006123A1 (en) | 1991-09-20 | 1992-09-16 | Human cyclin e |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE273386T1 true ATE273386T1 (de) | 2004-08-15 |
Family
ID=25070333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92920511T ATE273386T1 (de) | 1991-09-20 | 1992-09-16 | Menschliches cyclin e |
Country Status (7)
| Country | Link |
|---|---|
| US (5) | US5449755A (de) |
| EP (1) | EP0604560B1 (de) |
| JP (2) | JPH07502164A (de) |
| AT (1) | ATE273386T1 (de) |
| CA (1) | CA2119443C (de) |
| DE (1) | DE69233399T2 (de) |
| WO (1) | WO1993006123A1 (de) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07502164A (ja) * | 1991-09-20 | 1995-03-09 | フレッド ハッチンソン キャンサー リサーチ センター | ヒトサイクリンe |
| US5596079A (en) * | 1991-12-16 | 1997-01-21 | Smith; James R. | Mimetics of senescent cell derived inhibitors of DNA synthesis |
| US6372249B1 (en) | 1991-12-16 | 2002-04-16 | Baylor College Of Medicine | Senscent cell-derived inhibitors of DNA synthesis |
| US5484727A (en) * | 1992-10-14 | 1996-01-16 | Trustees Of Dartmouth College | Cloned gene encoding acylcoenzyme A: cholesterol acyltransferase (ACAT) |
| US5543291A (en) * | 1993-01-29 | 1996-08-06 | Dana Farber Cancer Institute | Method of detecting carcinoma |
| US5443962A (en) * | 1993-06-04 | 1995-08-22 | Mitotix, Inc. | Methods of identifying inhibitors of cdc25 phosphatase |
| US5625031A (en) * | 1994-02-08 | 1997-04-29 | Bristol-Myers Squibb Company | Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein |
| DE19539130C2 (de) * | 1995-02-28 | 1999-05-12 | Max Planck Gesellschaft | Mittel zur Therapie von Tumoren und anderen Hyperplasien |
| AU7015396A (en) * | 1995-09-07 | 1997-03-27 | Health Research Incorporated | Cyclin e variants and use thereof |
| US20030086927A1 (en) * | 1995-11-01 | 2003-05-08 | University Of Southern California | Expression of cyclin G1 in tumors |
| GB9613418D0 (en) * | 1996-06-26 | 1996-08-28 | Crc Technology Ltd | A cell-free system for initiation of DNA replication |
| JP2000515744A (ja) * | 1996-07-24 | 2000-11-28 | ファルマシア・アンド・アップジョン・カンパニー | サイクリンeの構築体および複合体 |
| US6274312B1 (en) | 1996-12-11 | 2001-08-14 | Schering Corporation | Intracellular regulatory molecules; related reagents |
| ATE261125T1 (de) * | 1997-05-20 | 2004-03-15 | Univ Erasmus | Erkennung von tmorspezifische genprodukte |
| US5843721A (en) * | 1997-07-03 | 1998-12-01 | Tularik Inc. | Nucleic acids encoding human NIK protein |
| GB9718913D0 (en) | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
| US6569878B1 (en) * | 1997-10-27 | 2003-05-27 | Agouron Pharmaceuticals Inc. | Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors |
| US5973119A (en) | 1998-06-05 | 1999-10-26 | Amgen Inc. | Cyclin E genes and proteins |
| US6624171B1 (en) * | 1999-03-04 | 2003-09-23 | Smithkline Beecham Corporation | Substituted aza-oxindole derivatives |
| US6492398B1 (en) | 1999-03-04 | 2002-12-10 | Smithkline Beechman Corporation | Thiazoloindolinone compounds |
| GB9904933D0 (en) * | 1999-03-04 | 1999-04-28 | Glaxo Group Ltd | Compounds |
| EP1190047A1 (de) * | 1999-06-23 | 2002-03-27 | Angiogene, Inc. | Antisense oligonukleotide die cyclin e genexpression modulieren und deren therapeutische verwendungen |
| CA2385879A1 (en) * | 1999-09-23 | 2001-03-29 | Rigel Pharmaceuticals, Inc. | Traf4 associated cell cycle proteins, compositions and methods of use |
| US6864355B1 (en) | 2000-05-02 | 2005-03-08 | Yale University | Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain |
| US6589725B1 (en) * | 1999-10-25 | 2003-07-08 | Rigel Pharmaceuticals, Inc. | Tankyrase H, compositions involved in the cell cycle and methods of use |
| US6887675B1 (en) | 1999-10-25 | 2005-05-03 | Rigel Pharmaceuticals, Inc. | Tankyrase H, compositions involved in the cell cycle and methods of use |
| US20030236300A1 (en) * | 1999-10-27 | 2003-12-25 | Yale University | Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| US20030149113A1 (en) * | 2001-10-12 | 2003-08-07 | Caplan Michael J. | Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| ES2341842T3 (es) | 2000-01-12 | 2010-06-29 | Yale University | Bloqueo del crecimiento axonal mediado por el receptor de nogo. |
| US20030175817A1 (en) * | 2000-02-10 | 2003-09-18 | Kyoji Ikeda | Method of screening for antiandrogen agent |
| US6620818B1 (en) | 2000-03-01 | 2003-09-16 | Smithkline Beecham Corporation | Method for reducing the severity of side effects of chemotherapy and/or radiation therapy |
| CN1322733A (zh) * | 2000-05-09 | 2001-11-21 | 上海博德基因开发有限公司 | 一种新的多肽——人npat蛋白11和编码这种多肽的多核苷酸 |
| EP1685379A4 (de) * | 2003-07-11 | 2007-07-11 | Merck & Co Inc | Verfahren zur identifizierung von zelloberflächen-rezeptorprotein-modulatoren |
| ATE452995T1 (de) | 2004-04-22 | 2010-01-15 | Ortho Mcneil Pharm Inc | Hdm2-inhibitorkomplexe und verwendungen davon |
| WO2007011702A2 (en) * | 2005-07-15 | 2007-01-25 | The University Of North Carolina At Chapel Hill | Use of egfr inhibitors to prevent or treat obesity |
| US20170117214A1 (en) | 2009-01-05 | 2017-04-27 | Amkor Technology, Inc. | Semiconductor device with through-mold via |
| US12019081B2 (en) | 2020-11-06 | 2024-06-25 | University Of Kentucky Research Foundation | Method for detection and quantification of CLN3 protein |
| CN116217722B (zh) * | 2023-03-22 | 2023-09-15 | 广东省第二人民医院(广东省卫生应急医院) | 一种抗CyclinE蛋白的纳米抗体及编码基因和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2658204A1 (fr) * | 1990-02-12 | 1991-08-16 | Inst Nat Sante Rech Med | Nouvelles compositions de cycline a humaine, sequence nucleotidique correspondante, et agents de detection ou de diagnostic de mutations hepatocellulaires induites par le virus hbv. |
| JPH07502164A (ja) * | 1991-09-20 | 1995-03-09 | フレッド ハッチンソン キャンサー リサーチ センター | ヒトサイクリンe |
| US5543291A (en) * | 1993-01-29 | 1996-08-06 | Dana Farber Cancer Institute | Method of detecting carcinoma |
-
1992
- 1992-09-16 JP JP5506220A patent/JPH07502164A/ja not_active Ceased
- 1992-09-16 AT AT92920511T patent/ATE273386T1/de not_active IP Right Cessation
- 1992-09-16 DE DE69233399T patent/DE69233399T2/de not_active Expired - Fee Related
- 1992-09-16 WO PCT/US1992/007866 patent/WO1993006123A1/en not_active Ceased
- 1992-09-16 EP EP92920511A patent/EP0604560B1/de not_active Expired - Lifetime
- 1992-09-16 CA CA002119443A patent/CA2119443C/en not_active Expired - Fee Related
- 1992-09-16 US US07/947,311 patent/US5449755A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/522,166 patent/US5783661A/en not_active Expired - Lifetime
- 1995-06-07 US US08/488,382 patent/US5807698A/en not_active Expired - Lifetime
- 1995-06-07 US US08/480,912 patent/US5861259A/en not_active Expired - Lifetime
- 1995-06-07 US US08/485,859 patent/US5645999A/en not_active Expired - Lifetime
-
2004
- 2004-02-25 JP JP2004050554A patent/JP2004222728A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE69233399D1 (de) | 2004-09-16 |
| EP0604560A1 (de) | 1994-07-06 |
| CA2119443C (en) | 1999-11-02 |
| AU676137B2 (en) | 1997-03-06 |
| US5449755A (en) | 1995-09-12 |
| AU2666392A (en) | 1993-04-27 |
| DE69233399T2 (de) | 2005-08-04 |
| EP0604560B1 (de) | 2004-08-11 |
| US5645999A (en) | 1997-07-08 |
| CA2119443A1 (en) | 1993-04-01 |
| WO1993006123A1 (en) | 1993-04-01 |
| JP2004222728A (ja) | 2004-08-12 |
| US5807698A (en) | 1998-09-15 |
| US5861259A (en) | 1999-01-19 |
| US5783661A (en) | 1998-07-21 |
| JPH07502164A (ja) | 1995-03-09 |
| EP0604560A4 (de) | 1995-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE273386T1 (de) | Menschliches cyclin e | |
| GR3025596T3 (en) | Compositions and methods for identifying biologically active molecules. | |
| DE68924816D1 (de) | Sitzanordnung zur Verwendung in Fahrzeugen. | |
| NO873933D0 (no) | Permeabilitetsstabilisering i underjordiske formasjoner inneholdende partikkelformig materiale. | |
| DE69030959D1 (de) | EEPROM mit Referenzzelle | |
| DE69106135D1 (de) | Quasi-azeotrope Mischungen zur Verwendung als Kältemittel. | |
| DE69300156D1 (de) | Gehänge zur Verwendung in Förderern. | |
| FI882334L (fi) | Foerbaettrad polyetylenfibermassa. | |
| IL60961A (en) | Beta-galactosyl-umbelliferone-labeled protein or polypeptide conjugates and their use in immunoassay methods | |
| DE68904358D1 (de) | Prostaglandinanaloge zur verwendung in der medizin. | |
| DE58903324D1 (de) | Pflanzliche wirkstoffzubereitung zur verwendung in kosmetika. | |
| DE69013129D1 (de) | Vorrichtung zur Zellfärbung. | |
| FI922409L (fi) | Foerfarande foer cellodling. | |
| DE3851007D1 (de) | Zusammensetzung zur Verwendung in der Landwirtschaft. | |
| ATE71149T1 (de) | Monoklonale antikoerper. | |
| NO883418L (no) | Biologisk dekkskive. | |
| FR2689904B1 (fr) | Test de bronzage épidermique in vitro. | |
| IT1230214B (it) | Coperchio scorrevole in materiale trasparente. | |
| DE69006421D1 (de) | Aussparung in Arbeitsplatten mit niedriger Spannungs-Konzentration. | |
| DE3781745D1 (de) | Antikoerper zur verwendung fuer die bestimmung von menschlichem glycoalbumin. | |
| NO161078C (no) | Testsett for bestemmelse av mikroorganismen streptococcusmutans i menneskesaliva. | |
| ATA160189A (de) | Zubereitungen zur verwendung in der bauindustrie | |
| DE68906167D1 (de) | Zusammensetzung zur erkennung von paradontalen krankheiten. | |
| DE69110861D1 (de) | Mittel zur verbesserung des kollagenmetabolismus und dessen verwendung. | |
| FR2657879B1 (fr) | Plaque de culture cellulaire. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |